中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

MRI of Myocardial Infarction

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态招聘中
赞助商
University of Pennsylvania

关键词

抽象

Heart failure (HF) is an enormous health burden affecting approximately 5.1 million people in the US and is the cause of 250,000 deaths each year. Approximately 50% of HF is caused by myocardial ischemia and requires immediate restoration of coronary blood flow to the affected myocardium. However, the success of reperfusion is partly limited by intramyocardial hemorrhage, which is the deposition of intravascular material into the myocardium. Hemorrhagic reperfusion injury has high prevalence and patients have a much greater risk of adverse left ventricular remodeling, risk of fatal arrhythmia, impaired systolic function and are hospitalized at a greater rate. Recent magnetic resonance imaging techniques have improved assessment of reperfusion injury, however, the association between MRI contrasts and reperfusion injury is highly unclear, and lacks specificity to IMH. Improved imaging of IMH and accurate knowledge about its spatial and temporal evolution may be essential for delivery of optimal medical therapy in patients and critical to identify patients most at risk for adverse ventricular remodeling. The overall goal is to investigate the magnetic properties of hemorrhage and develop MRI techniques with improved specificity to hemorrhage. New MRI techniques permit noninvasive assessment of the magnetic susceptibility of tissues and can target tissue iron. Therefore, the investigators hypothesize that MRI imaging of myocardial magnetic susceptibility can map hemorrhagic myocardium. The investigators will perform a longitudinal observational study in patients after reperfusion injury to validate these methods, compare the methods with conventional MR contrasts and develop MR methods for imaging humans.

日期

最后验证: 05/31/2020
首次提交: 05/07/2018
提交的预估入学人数: 05/07/2018
首次发布: 05/20/2018
上次提交的更新: 06/22/2020
最近更新发布: 06/24/2020
实际学习开始日期: 03/31/2018
预计主要完成日期: 03/30/2023
预计完成日期: 03/30/2023

状况或疾病

Myocardial Infarction
Myocardial Ischemia
Myocardial Injury
Myocardial Fibrosis
Myocardial Reperfusion Injury
Myocardial Edema
Myocardial Necrosis
Heart Failure
Ischemic Heart Disease
Ischemic Cardiomyopathy
Hemorrhage

-

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
取样方式Probability Sample
接受健康志愿者
标准

Inclusion Criteria:

- Between the ages of 18 and 80

- Patients must be able to read and understand English

- Participants must sign the informed consent form

- Elevated and delayed peak creatine kinase-MB and troponin I (cTnI) and troponin T (cTnT) in blood serum,

- ST elevation detected on ECG

Exclusion Criteria:

- contraindications to cardiac MRI, including claustrophobia

- advanced renal disease (estimated glomerular filtration rate 30 mL/min) or hypersensitivity to gadolinium

- presence of a cardiac pacemaker or implanted cardiac cardioverter defibrillator

- pregnancy

- personal or family history of hypertrophic cardiomyopathy

- inability to provide informed consent

- history of seizure disorder

结果

主要结果指标

1. ejection fraction [<36 hours to >6 months]

次要成果指标

1. relaxation times [<36 hours to >6 months]

2. extracellular volume fraction [<36 hours to >6 months]

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge